News & Updates

Novel tenofovir formulation noninferior to disoproxil fumarate in chronic hepatitis B
Novel tenofovir formulation noninferior to disoproxil fumarate in chronic hepatitis B
08 Nov 2021

In the treatment of patients with chronic hepatitis B (CHB), the novel tenofovir amibufenamide (TMF) is as good as tenofovir disoproxil fumarate (TDF) in terms of efficacy but with the advantage of better bone and renal safety, according to the results of a noninferiority trial.

Novel tenofovir formulation noninferior to disoproxil fumarate in chronic hepatitis B
08 Nov 2021
Spike mutations in COVID-19 variants threaten vaccine efficacy
Spike mutations in COVID-19 variants threaten vaccine efficacy
04 Nov 2021
Do mRNA COVID-19 vaccines influence treatment for rheumatic diseases?
Do mRNA COVID-19 vaccines influence treatment for rheumatic diseases?
02 Nov 2021 byAudrey Abella

In individuals receiving disease-modifying antirheumatic drugs* (DMARDs) for inflammatory rheumatic diseases** (IRD), humoral response remained satisfactory following administration of the second dose of the Pfizer mRNA vaccine against SARS-CoV-2, a study suggests.

Do mRNA COVID-19 vaccines influence treatment for rheumatic diseases?
02 Nov 2021
Cancer patients bear brunt of COVID-19 pandemic
Cancer patients bear brunt of COVID-19 pandemic
01 Nov 2021

The COVID-19 pandemic has evidently affected the care and well-being of cancer patients, particularly those with advanced stages, reveals a recent study.

Cancer patients bear brunt of COVID-19 pandemic
01 Nov 2021